Secondary non-resectable liver tumors: A single-center living-donor and deceased-donor liver transplantation case series

ConclusionsThe more recent LDLT series compared favorably to our DDLT series in the treatment of secondary liver malignancies. The absence of portal hypertension and the use of smaller left grafts make recipient and donor surgeries safe. The safety of the procedures and lack of interference with the scarce allograft pool are expected to lead to a more frequent use of LDLT in the field of transplant oncology.
Source: Hepatobiliary and Pancreatic Diseases International - Category: Gastroenterology Source Type: research